FDAnews
www.fdanews.com/articles/173268-bolton-receives-ce-mark-approval-for-abdominal-stent-graft-system

Bolton Receives CE Mark Approval for Abdominal Stent-Graft System

September 25, 2015

Bolton Medical has received CE Mark for its Treo Abdominal Stent-Graft System used to treat abdominal aortic aneurysms.

According to the Sunrise, Fla.-based company, the three-piece system offers a wide range of sizes that allows for precise treatment and greater patient applicability.

Treo is the latest addition to the Bolton’s abdominal product portfolio.

Bolton is a subsidiary of the WerfenLife Co., which manufactures and distributes medical diagnostic solutions and medical devices around the globe. — Michael Cipriano